Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings
About Vcanbio Cell & Gene Engineering Corp., Ltd
Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中源协和细胞基因工程股份有限公司审计报告 | 2023-04-25 | Chinese | |
| 独立董事候选人声明（侯欣一） | 2023-04-25 | Chinese | |
| 中源协和细胞基因工程股份有限公司董事会审计委员会2022年度履职情况报告 | 2023-04-25 | Chinese | |
| 中源协和细胞基因工程股份有限公司关于计提资产减值损失的公告 | 2023-04-25 | Chinese | |
| 中源协和细胞基因工程股份有限公司十届十四次监事会会议决议公告 | 2023-04-25 | Chinese | |
| 中源协和细胞基因工程股份有限公司2022年度独立董事述职报告 | 2023-04-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 41325821 | 中源协和细胞基因工程股份有限公司审计报告 | 2023-04-25 | Chinese | ||
| 41325634 | 独立董事候选人声明（侯欣一） | 2023-04-25 | Chinese | ||
| 41325618 | 中源协和细胞基因工程股份有限公司董事会审计委员会2022年度履职情况报告 | 2023-04-25 | Chinese | ||
| 41325612 | 中源协和细胞基因工程股份有限公司关于计提资产减值损失的公告 | 2023-04-25 | Chinese | ||
| 41325604 | 中源协和细胞基因工程股份有限公司十届十四次监事会会议决议公告 | 2023-04-25 | Chinese | ||
| 41325592 | 中源协和细胞基因工程股份有限公司2022年度独立董事述职报告 | 2023-04-25 | Chinese | ||
| 41325581 | 中源协和细胞基因工程股份有限公司关于选举第十一届监事会职工监事的公告 | 2023-04-25 | Chinese | ||
| 41325571 | 中源协和细胞基因工程股份有限公司独立董事关于计提资产减值损失的独立意见 | 2023-04-25 | Chinese | ||
| 41325559 | 中源协和细胞基因工程股份有限公司独立董事关于关联交易事项的事前认可意见 | 2023-04-25 | Chinese | ||
| 41325548 | 中源协和细胞基因工程股份有限公司2023年第一季度报告 | 2023-04-25 | Chinese | ||
| 41325537 | 中源协和细胞基因工程股份有限公司独立董事关于2022年度内部控制评价报告的独立意见 | 2023-04-25 | Chinese | ||
| 41325529 | 独立董事候选人声明（裴端卿） | 2023-04-25 | Chinese | ||
| 41325522 | 中源协和细胞基因工程股份有限公司2022年年度报告 | 2023-04-25 | Chinese | ||
| 41325434 | 中源协和细胞基因工程股份有限公司关于召开2022年年度股东大会的通知 | 2023-04-25 | Chinese | ||
| 41325404 | 中源协和细胞基因工程股份有限公司2022年度募集资金存放与实际使用情况的专项报告 | 2023-04-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Vcanbio Cell & Gene Engineering Corp., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56891/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56891 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56891 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56891 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56891}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vcanbio Cell & Gene Engineering Corp., Ltd (id: 56891)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.